AHA/ASA guideline recommendations for prevention of stroke in women menopause and postmenopausal hormonal therapy: Difference between revisions

< AHA
Jump to navigation Jump to search
No edit summary
m (Bot: Adding CME Category::Cardiology)
 
Line 15: Line 15:
==References==
==References==
{{reflist|2}}
{{reflist|2}}
{{WS}}
{{WH}}
[[CME Category::Cardiology]]


[[Category:Aging-associated diseases]]
[[Category:Aging-associated diseases]]
Line 27: Line 31:
[[Category:Disease]]
[[Category:Disease]]
[[Category:Needs overview]]
[[Category:Needs overview]]
{{WS}}
{{WH}}

Latest revision as of 19:35, 14 March 2016

Stroke Main page

Patient Information

Overview

Causes

Classification

Hemorrhagic stroke
Ischemic stroke

Differentiating Stroke from other Diseases

Epidemiology and Demographics

Diagnosis

NIH stroke scale
Glasgow coma scale

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Interventions

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

AHA/ASA guideline recommendations for prevention of stroke in women menopause and postmenopausal hormonal therapy On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of AHA/ASA guideline recommendations for prevention of stroke in women menopause and postmenopausal hormonal therapy

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on AHA/ASA guideline recommendations for prevention of stroke in women menopause and postmenopausal hormonal therapy

CDC on AHA/ASA guideline recommendations for prevention of stroke in women menopause and postmenopausal hormonal therapy

AHA/ASA guideline recommendations for prevention of stroke in women menopause and postmenopausal hormonal therapy in the news

Blogs on AHA/ASA guideline recommendations for prevention of stroke in women menopause and postmenopausal hormonal therapy

Directions to Hospitals Treating Psoriasis

Risk calculators and risk factors for AHA/ASA guideline recommendations for prevention of stroke in women menopause and postmenopausal hormonal therapy

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ayokunle Olubaniyi, M.B,B.S [2]

2014 AHA/ASA Guideline Recommendations for Prevention of Stroke in Women (DO NOT EDIT)[1]

Postmenopausal Hormonal Therapy

Class III (No Benefit)
"1. HT (CEE with or without medroxyprogesterone) should not be used for primary or secondary prevention of stroke in postmenopausal women. (Level of Evidence: A) "
"2. Selective estrogen receptor modulators, such as raloxifene, tamoxifen, or tibolone, should not be used for primary prevention of stroke. (Level of Evidence: A) "

References

  1. Bushnell C, McCullough LD, Awad IA, Chireau MV, Fedder WN, Furie KL; et al. (2014). "Guidelines for the Prevention of Stroke in Women: A Statement for Healthcare Professionals From the American Heart Association/American Stroke Association". Stroke. doi:10.1161/01.str.0000442009.06663.48. PMID 24503673.

Template:WS Template:WH CME Category::Cardiology